Logo for Basque Engineering

Video Recordings of Presentations

Online Conference Series on

‘Sourcing Biospecimens for Industry R&D’

Part 1

Logo for Modul-Bio

See Recordings Below

The October conference (part 1 of the series) attracted 330 registrants, of which 50% were from Biotech or Pharma companies and 34% were from non-commercial organizations (mostly academic biobanks). We had some great talks with a lot of questions from the audience. Post-conference feedback about the speakers and topics was very positive. Feel free to view the recordings below and see what you think!

Register Now for the Next Part!

The November conference (part 2 of the series) is on Thursday 24th November. 

Video Recordings of Speaker Presentations

Improving access to biospecimens and data from human health biobanks

Jennifer A. Byrne, PhD

Director of Biobanking, NSW Health Pathology, NSW Health Statewide Biobank, Camperdown, NSW. Professor of Molecular Oncology, Faculty of Medicine and Health, The University of Sydney, NSW.

Human health biobanks provide biospecimens and data to drive biomedical and health research. Most biobanks required continuous financial and in-kind support to accrue, add value to, and distribute biospecimens and data. The requirement for continuous operational support can result in many human research biobanks reporting sustainability challenges. The sustained support of biobanks can be particularly difficult to justify when biobanks and their services are underused, relative to supporting investments. This presentation will discuss human health biobank underuse and approaches that aim to improve the research use of biobanks, such as prospective biobanking models. The presentation will conclude with an open discussion of how human health biobanks and their biospecimen and data collections can be rendered more visible and appealing to a broader range of research users.

The Mission of Biosample Hub

Robert Hewitt, Apoorva Srinivasan, and Sakshi Setia

Biosample Hub.

This presentation explains the mission of Biosample Hub, which is briefly, to connect Biotechs and Biobanks.

We explain why this mission is important and the steps we are taking to achieve it.

The Singapore Translational Cancer Consortium

Eng Chon Boon, PhD

NUH Tissue Repository and Hospital-based Cancer Registry

Singapore Translational Cancer Consortium (STCC) was established in 2020 as a nationally coordinated initiative and network to synergize cancer research and translational capabilities across Singapore. It aims to bring together Singapore’s best basic, clinical and translational talent in Singapore, and advance global research and translational competitiveness to the next level by establishing and implementing collaborative cancer research programs originating from the local cancer research community as well as partnerships from the industry.

Regulations governing import and export of samples. Sant Joan de Déu Biobank experience in national and international sample sharing

Anna Codina Bergadà, MSc

Bióloga en Hospital Sant Joan de Déu Barcelona

Increasingly, biological sample sharing between laboratories or hospitals as a part of research collaboration and networking is becoming essential and it is a key point for scientific understanding and improvement. This is even more important when rare disease research is the focus, as the more cases and samples you have the stronger and robust will be the study and consequently its results. Besides, there are some diagnostic tests that are not performed as a routine in all hospitals or laboratories, and samples have to be sent to reference laboratories for medical results. Either way, import and export of biological samples should be an essential workflow in all laboratories at present. Medical centers, laboratories or hospitals must have a fluent workflow in sharing samples, with standardized protocols and documentation that ensure the quality of samples. Maintaining the temperature of samples during the travel time, selecting other adequate conditions such as the proper box as well as box labels and documentation elaboration, are some of the keys to make a successful exchange of biological material.

Session on Biobank Quality Standards

ISO 20387: Conformity Assessment for Biobanking and its Industrial Relevance

Clare M. Allocca, PMP

Senior Adviser for Planning and Outreach, National Institute of Standards and Technology (NIST), MD, USA

ISO 20387 Biotechnology – Biobanking – General requirements for biobanking is an international conformity assessment standard that contains requirements to enable biobanks to demonstrate competent biobank operation and the ability to provide biological material and associated data (BMaD) of appropriate quality for research and development. This is intended to be achieved by the planning and implementation of policies, processes and procedures covering the life cycle of biological materials and their associated data. The use of this document facilitates cooperation, fosters exchange, and assists in the harmonization of practices among biobanks, researchers and other parties. Biobankers from around the globe worked for several years to develop this document based on input and perceived needs of the user. Now that ISO 20387 has been published for several years, what can be said about its progress in pursuit of fitness for purpose in biobanking, and how does that translate to the users of biospecimens? As with everything, it is all about the value proposition, including risk: • For Biobanks: balance of fitness-for-purpose needs and level of assurance required by users versus available resources • For Accreditation Bodies (ABs): evidence of sufficient demand for accreditation to standard to justify investment to set up program; as well as availability of assessors • For Industry / Users: amount of assurance needed for a specific purpose; identification and communication of key requirements for biospecimens; needs of product users further down the chain… This value proposition will be explored along with considerations that affect all interested parties, including industry. These experiences, as well as other input from users, will inform the next revision of ISO 20387 in 2023.

Paving the path towards the highest international quality standards in biobanking

Agnieszka Matera-Witkiewicz, PhD, R&D PM

Head, Wroclaw Medical University Biobank, Wroclaw, Poland

Wroclaw Medical University Biobank (WMU Biobank) has been established in 2017 as a key project listed within three scientific strategic activities proposed for Wroclaw Medical University in 2016-2020: Translational Medicine/Integrated Biobank; Healthy Aging and Clinical Epidemiology. WMU Biobank was created to ensure the enhancement of biological material availability not only for internal cooperation but also for external partners, where the highest quality standards will be accomplished. An important goal for the biobank management was the aspiration for key certificates achievement to confirm that it operates on the basis of QMS convergent with the requirements of ISO 9001 and ISO 20387. A leading objective was also the fulfilment of the QMS-Self Assessment Survey requirements and positive audit results supervised by QM BBMRI-ERIC. Paving the path towards the highest international quality standards in biobanking is a case study how quality aspects have been organized and implemented in WMU Biobank. Moreover, it presents a success story of first biobanking ISO 9001:2015 certification and IS)20387:2021-01 accreditation in Poland.


Importance of Biospecimens in the Drug Development Process for Post-traumatic Stress Disorder and Traumatic Brain Injury

Nicole Bjorklund, PhD

Cohen Veterans Bioscience, New York, USA

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics. There is a huge unmet need for diagnostics and therapeutics in the diseases of PTSD and TBI. Different studies on plasma biomarkers in PTSD show major inconsistencies. So, there is a need for standardized collection and storage procedures to ensure more meaningful results.

Sponsored Presentations

Gold sponsor: Basque Engineering + Science

Viewed by 45 attendees during the conference

Silver sponsor: Modul-Bio

Viewed by 50 attendees during the conference

Bronze sponsor: AgileBio

Viewed by 54 attendees during the conference